AAII ETF Evaluator

ETF Evaluator: CapForce IBD® 50 ETF (FFTY) Follow This ETF

Equity
Global Asset Class
U.S. Equity
Fund Group
Mid-Cap Growth
Category
$37.170
Last Trade
(as of Aug 18)
$ 80 Mil
Share Class Assets
1.27%
TTM Yield
$44.080 - $31.610
52-Wk High-Low Range
0.80% F
Expense Ratio
1209%
Portfolio Turnover
30 (k)
Avg. Daily Trading Vol.
Data as of 7/31/2026
-15.3% F (NAV)
-15.1% F (Price)
1-Mo Return
-3.0% F (NAV)
-2.9% F (Price)
3-Mo Return
6.1% D (NAV)
6.3% D (Price)
YTD Return
9.5% D (NAV)
9.5% D (Price)
1-Yr Return
12.8% C (NAV)
12.8% D (Price)
3-Yr Return
-2.8% F (NAV)
-2.8% F (Price)
5-Yr Return
1.42 F
Category
Risk
Index
2.45
Total
Risk
Index

ETF Details

Fund Family
Capital-FORCE ETF

Inception Date
4/8/2015

Website

Phone
800-208-5212

Primary Benchmark
S&P 500 (TR) (1970): 100%

Secondary Benchmark
IBD 50 Index USD: 100%

Additional Fund Details

CapForce IBD® 50 ETF Overview

CapForce IBD® 50 ETF (FFTY) is a passively managed U.S. Equity Mid-Cap Growth exchange-traded fund (ETF). Capital-FORCE ETF launched the ETF in 2015.

The investment seeks to track, before fees and expenses, the performance of the IBD® 50 Index (the "index"). The fund will normally invest at least 80% of its net assets (including investment borrowings) in securities that comprise the index. The IBD® 50 Index is a weekly, rules-based, computer-generated stock index compiled and published by Investor's Business Daily® ("IBD" or the "index provider") that seeks to identify the current top 50 growth stocks.

About CapForce IBD® 50 ETF (FFTY)

There are 3 members of the management team with an average tenure of 6.47 years: Dustin Lewellyn (2017), Ernesto Tong (2017) and Christine Johanson (2024). Management tenure is more important for actively managed ETFs than passive index ETFs.

The ETF has 2 primary benchmarks: S&P 500 (TR) (1970) index with a weighting of 100% and IBD 50 Index USD index with a weighting of 100%. CapForce IBD® 50 ETF has 50 securities in its portfolio. The top 10 holdings constitute 34.9% of the ETF’s assets. The ETF meets the SEC requirement of being classified as a diversified fund. The ETF is not considered to have an ESG focus with its investment selection and management.

CapForce IBD® 50 ETF is part of the Equity global asset class and is within the U.S. Equity ETF group. CapForce IBD® 50 ETF has 3.7% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 96.4% There is 3.7% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). CapForce IBD® 50 ETF has 0.0% of the portfolio in cash.

Assets Under Management

The fund has $79 million in total assets, which is below the $1 billion average for the Mid-Cap Growth category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.

FFTY Performance and Fees

The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The CapForce IBD® 50 ETF expense ratio is high compared to funds in the Mid-Cap Growth category. CapForce IBD® 50 ETF has an expense ratio of 0.80%, which is 52% higher than its category average, making the fund expense ratio grade a F. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.

High portfolio turnover can translate to higher expenses and lower aftertax returns. CapForce IBD® 50 ETF has a portfolio turnover rate of 1209%, which indicates that it holds its assets around / 0.0 years. By way of comparison, the average portfolio turnover is 166% for the Mid-Cap Growth category.

Recently, in the month of July 2026, CapForce IBD® 50 ETF returned -15.3%, which earned it a grade of F, as the Mid-Cap Growth category had an average return of -6.0%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all ETFs in that category.

CapForce IBD® 50 ETF has a trailing yield of 1.27%, which is above the 0.41% category average. The fund normally distributes its income annually.

It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.

CapForce IBD® 50 ETF Grades

Year to date, the ETF has returned 6.1%, 3.4 percentage points worse than the category, which translates into a grade of D. The fund has returned 9.5% over the past year (grade of D), 12.8% over the past three years (grade of C) and -2.8% per year over the past five years (grade of F) and 5.4% per year over the past 10 years (grade of F).

For more ETF grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.

Otherwise, for more information about CapForce IBD® 50 ETF, including its riskiness, submit your email to unlock the rest of the article.


FFTY Trailing NAV Total Returns Data as of 7/31/26

Last
Month
Last
Quarter
Ann'l.
1Yr
Ann'l.
3Yr
Ann'l.
5Yr
Ann'l.
10Yr
FFTY Return (NAV) -15.3% -3.0% 9.5% 12.8% -2.8% 5.4%
FFTY Return (Price) -15.1% -2.9% 9.5% 12.8% -2.8% 5.4%
NAV +/- Price Return -0.229% -0.041% 0.022% 0.014% -0.011% -0.004%
Mid-Cap Growth Avg -6.0% 2.2% 13.8% 14.5% 4.1% 11.9%
FFTY Grade (NAV) F F D C F F
+/- Category (NAV) -9.3% -5.2% -4.2% -1.7% -6.9% -6.5%
FFTY Tax-Cost Ratio na na 0.5% 0.4% 0.4% 0.2%

FFTY Annual NAV Total ReturnsData as of 7/31/26

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
FFTY Return (NAV) 6.1% 23.5% 18.6% 12.3% -51.0% 11.9% 18.0% 25.8% -16.6% 37.3% 9.1%
FFTY Return (Price) 6.3% 23.4% 18.6% 12.4% -51.1% 11.9% 18.2% 25.7% -16.8% 37.6% 8.9%
NAV +/- Price Ret 0.029% -0.006% -0.003% 0.008% 0.001% -0.002% 0.011% -0.1% 0.8% 0.8% -2.0%
Mid-Cap Growth Avg 9.5% 11.5% 20.5% 23.6% -30.6% 9.4% 50.3% 29.2% -8.2% 29.5% 7.9%
FFTY Grade (NAV) D A C F F C F F F A B
+/- Category -3.4% 12.1% -1.9% -11.3% -20.4% 2.6% -32.2% -3.4% -8.4% 7.8% 1.2%
Risk Measures
Beta: 1.74
R-Squared: 57%
Standard Deviation: 30.0%
Category Risk Index: 1.42
Category Risk Rating: High
Total Risk Index: 2.45
Total Risk Rating: High
Portfolio Characteristics
Yield: 1.3%
Total Assets: $ 80 Mil
Share Class Assets: $ 80 Mil
Turnover: 1209.0%
Expense Ratio: 0.80%
Index Fund: Yes
Index Tracked: S&P 500 (TR) (1970)
Index Weighting: 100%
Leveraged: No
Socially Responsible Fund: No
Capital Gains Distribution Frequency:
Income Distribution Frequency: Annually

Management Team

Number of Managers: 3
Longest Tenure: 8.7 years
Average Tenure: 6.5 years
Managers (Year): Lewellyn Dustin (2017), Tong Ernesto (2017), Johanson Christine (2024)

Portfolio Composition (as of 7/31/26)

# of Holdings: 50
% in Top 10 Holdings: 34.9%
Fund is Non-Diversified: No
% in Foreign Issues: 3.7%
 

Portfolio Allocation

Domestic Stock: 96.4%
Foreign Stock: 3.7%
Preferred Stock: 0.0%
Domestic Bond: 0.0%
Foreign Bond: 0.0%
Convertible Bond: 0.0%
Other: 0.0%
Cash: 0.0%

Purchase Information

Legal Structure: Open Ended Investment Company
Fund Family: Capital-FORCE ETF
Phone Number: 800-208-5212
Website: www.innovatorfunds.com
Inception Date: April 8, 2015

Expenses and Fees

Expense Ratio (%): 0.80% (Rating: High)
Category Average Expense Ratio (%): 0.53%
Copyright 2026 American Association of Individual Investors and Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.